Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Not Confirmed
Not Confirmed
20-23 July, 2025
Not Confirmed
Not Confirmed
24-25 July, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
26-28 August, 2025
APGA Annual ConferenceAPGA Annual Conference
Industry Trade Show
Not Confirmed
20-23 July, 2025
Industry Trade Show
Not Confirmed
24-25 July, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/cdmo-activity-tracker-veranova-carbogen-lead-adc-investments-axplora-polfa-tarchomin-famar-expand-european-footprint
02 Apr 2025
// FIERCE PHARMA
https://www.fiercebiotech.com/biotech/pfizer-flagship-turn-autoimmune-tap-valo-health-latest-part-multibillion-dollar-collab
25 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250325969918/en/Charles-River-and-Valo-Health-Identify-a-Potential-Therapeutic-for-Lupus-Using-Logica-an-AI-Powered-Drug-Discovery-Platform
20 Mar 2025
// BUSINESSWIRE
https://www.businesswire.com/news/home/20250320583485/en/Valo-Health-Appoints-Accomplished-Executive-Peggy-Dalicandro-as-Vice-President-Head-of-Human-Resources
09 Jan 2025
// BIOSPACE
https://www.biospace.com/business/novo-puts-4-6b-on-the-line-to-expand-valo-deal-maintain-cardiometabolic-leadership
02 Jan 2025
// FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/valo-health-abandons-rock-inhibitor-after-phase-2-diabetic-retinopathy-fail
04 Mar 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/valo-health-completes-enrollment-of-opl-0401-phase-2-study-for-the-treatment-of-diabetic-retinopathy-302078247.html
ABOUT THIS PAGE